The study will look to confirm the tolerability of the combination and determine the optimal dose of Actimab-A when used with Venetoclax and ASTX-727. Dr. Avinash Desai, Actinium’s Chief Medical ...
The study will look to confirm the tolerability of the combination and determine the optimal dose of Actimab-A when used with Venetoclax and ASTX-727. Dr. Avinash Desai, Actinium’s Chief Medical ...
Pharmaceutical Technology on MSN3d
Telix’s new lead-212 generator could dispel medical isotope scalability hurdlesTelix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...
Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced an agreement with Claritev, Inc. ("Claritev") , previously MultiPlan, Inc. , a ...
According to Grand View Research, the global influenza vaccine market is expected to grow at an average annual rate of 8.5% ...
3d
Achieves alignment with U.S. Food and Drug Administration (FDA) on regulatory path for potential accelerated approval of iopofosine I 131 as a ...
MELBOURNE, Australia and INDIANAPOLIS, March 13, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that it has developed and validated ...
Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...
CLR 121225 is Cellectar’ s lead alpha-emitting (actinium-225) PRC, which has demonstrated activity ... You can identify these statements by our use of words such as “may,” “expect,” “believe,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback